QT Imaging prices $10 million public offering at $5 per share

QT Imaging Holdings Inc. (NASDAQ: QTI) announced the pricing of an underwritten public offering of 2 million shares of common stock or pre-funded warrants for gross proceeds of $10 million.

The medical device company set the public offering price at $5.00 per share. Pre-funded warrants are being sold at the same price minus a nominal exercise price of $0.0001 per share. Each pre-funded warrant will be immediately exercisable and entitles the holder to purchase one share of common stock.

Ladenburg Thalmann & Co. Inc. serves as sole book-running manager for the offering, with Northland Capital Markets acting as co-manager.

The company plans to use net proceeds for working capital and general corporate purposes. The offering is expected to close on or about May 18, 2026, subject to customary closing conditions.

"This financing along with the extension of the maturity date of our senior secured term loan by two years provide the Company with additional flexibility to focus on our commercial, clinical, and strategic growth initiatives," said Dr. Raluca Dinu, Chief Executive Officer of QT Imaging.

The securities are being offered under a shelf registration statement on Form S-3 that was declared effective by the Securities and Exchange Commission on April 3, 2026. QT Imaging develops medical imaging systems using low frequency sound waves for breast health applications.

You May Also Be Interested In

• Intelligent Bio Solutions raises $5M in private placement
• DeFi Development Corp. plans $20M preferred stock offering
• CleanCore Solutions rebrands as Zone Frontier, shifts to AI data centers